Bausch Health Companies (BHC) PT Lowered to $35 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Bausch Health Companies (BHC) PT Lowered to $14 at Stifel
November 3, 2022 1:23 PM EDTStifel analyst Annabel Samimy lowered the price target on Bausch Health Companies (NYSE: BHC) to $14.00 (from $15.00) while maintaining a Buy rating following results.
The analyst commented, "Remaining committed to the BLCO separation, BHC reported a lower 3Q22, with revenues of $2,046mn/Cons.... More
Bausch Health Co. Inc. (BHC) Tops Q3 EPS by 16c; Trims FY Revenue Outlook
November 3, 2022 7:17 AM EDTBausch Health Co. Inc. (NYSE: BHC) reported Q3 EPS of $1.10, $0.16 better than the analyst estimate of $0.94. Revenue for the quarter came in at $2.05 billion versus the consensus estimate of $2.07 billion.
GUIDANCE:
Bausch Health Co. Inc. sees FY2022 revenue of $8-8.17... More
Bausch Health Co. Inc. (BHC) November weekly option implied volatility into quarter results and outlook
November 2, 2022 10:09 AM EDTBausch Health Co. Inc. (NYSE: BHC) November weekly call option implied volatility is at 161, November is at 111; compared to its 52-week range of 33 to 243 into the expected release of quarter results on November 3.
... More